Loading…

Can gene editing and silencing technologies play a role in the treatment of head and neck cancer?

Highlights • Gene silencing and editing technology is now routine in the laboratory. • Advanced bioinformatics of head and neck cancer is required. • Clinically useful delivery systems and target selection are critical barriers. • The PLAS, nano-patch & microneedle approaches could be potential...

Full description

Saved in:
Bibliographic Details
Published in:Oral oncology 2017-05, Vol.68, p.9-19
Main Authors: Shaikh, Mushfiq H, Clarke, Daniel T.W, Johnson, Newell W, McMillan, Nigel A.J
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c435t-f170f58c47c1e9762744b1492d71a9b2f474b7289b7b96ed3a459b4de00037b13
cites cdi_FETCH-LOGICAL-c435t-f170f58c47c1e9762744b1492d71a9b2f474b7289b7b96ed3a459b4de00037b13
container_end_page 19
container_issue
container_start_page 9
container_title Oral oncology
container_volume 68
creator Shaikh, Mushfiq H
Clarke, Daniel T.W
Johnson, Newell W
McMillan, Nigel A.J
description Highlights • Gene silencing and editing technology is now routine in the laboratory. • Advanced bioinformatics of head and neck cancer is required. • Clinically useful delivery systems and target selection are critical barriers. • The PLAS, nano-patch & microneedle approaches could be potential delivery systems. • Targeting E6 & E7 could be an effective treatment strategy for HPV-positive HNSCC.
doi_str_mv 10.1016/j.oraloncology.2017.02.016
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1891889486</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1368837517300428</els_id><sourcerecordid>1891889486</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-f170f58c47c1e9762744b1492d71a9b2f474b7289b7b96ed3a459b4de00037b13</originalsourceid><addsrcrecordid>eNqNkU1v1DAQhiNERT_gLyCLE5cEfyW2OYDQQgGpUg-Fs-U4k11vvfZie5H239dhC0KcOHmsed95Nc80zSuCO4LJ8GbbxWR8DDb6uD52FBPRYdrV1pPmgkihWtwr9rTWbJCtZKI_by5z3mKMe9LjZ805lZxJqtRFY1YmoDUEQDC54sIamTCh7DwEu_wK2E1YchxktPfmiAxK0QNyAZUNoJLAlB2EguKMNmCmX_4A9h5ZEyyk98-bs9n4DC8e36vm-_Wnb6sv7c3t56-rDzet5awv7UwEnntpubAElBio4HwkXNFJEKNGOnPBR0GlGsWoBpiY4b0a-QR1KyZGwq6a16e5-xR_HCAXvXPZgvcmQDxkTaQiUiouhyp9e5LaFHNOMOt9cjuTjppgvSDWW_03Yr0g1pjq2qrml485h3EH0x_rb6ZV8PEkgLrtTwdJZ-sqzgo4gS16iu7_ct79M8Z6F5w1_h6OkLfxkELlqYnO1aDvlmMvtyaCYcypZA90SqiA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1891889486</pqid></control><display><type>article</type><title>Can gene editing and silencing technologies play a role in the treatment of head and neck cancer?</title><source>Elsevier</source><creator>Shaikh, Mushfiq H ; Clarke, Daniel T.W ; Johnson, Newell W ; McMillan, Nigel A.J</creator><creatorcontrib>Shaikh, Mushfiq H ; Clarke, Daniel T.W ; Johnson, Newell W ; McMillan, Nigel A.J</creatorcontrib><description>Highlights • Gene silencing and editing technology is now routine in the laboratory. • Advanced bioinformatics of head and neck cancer is required. • Clinically useful delivery systems and target selection are critical barriers. • The PLAS, nano-patch &amp; microneedle approaches could be potential delivery systems. • Targeting E6 &amp; E7 could be an effective treatment strategy for HPV-positive HNSCC.</description><identifier>ISSN: 1368-8375</identifier><identifier>EISSN: 1879-0593</identifier><identifier>DOI: 10.1016/j.oraloncology.2017.02.016</identifier><identifier>PMID: 28438299</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Carcinoma, Squamous Cell - therapy ; CRISPR/Cas ; Gene Editing ; Gene Silencing ; Head and Neck Neoplasms - therapy ; Head and neck squamous cell carcinoma ; Hematology, Oncology and Palliative Medicine ; Human papillomavirus ; Humans ; Nanoparticles and lipoplex ; Otolaryngology ; RNA Interference ; Short interfering RNA ; Squamous Cell Carcinoma of Head and Neck</subject><ispartof>Oral oncology, 2017-05, Vol.68, p.9-19</ispartof><rights>2017</rights><rights>Crown Copyright © 2017. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-f170f58c47c1e9762744b1492d71a9b2f474b7289b7b96ed3a459b4de00037b13</citedby><cites>FETCH-LOGICAL-c435t-f170f58c47c1e9762744b1492d71a9b2f474b7289b7b96ed3a459b4de00037b13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28438299$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shaikh, Mushfiq H</creatorcontrib><creatorcontrib>Clarke, Daniel T.W</creatorcontrib><creatorcontrib>Johnson, Newell W</creatorcontrib><creatorcontrib>McMillan, Nigel A.J</creatorcontrib><title>Can gene editing and silencing technologies play a role in the treatment of head and neck cancer?</title><title>Oral oncology</title><addtitle>Oral Oncol</addtitle><description>Highlights • Gene silencing and editing technology is now routine in the laboratory. • Advanced bioinformatics of head and neck cancer is required. • Clinically useful delivery systems and target selection are critical barriers. • The PLAS, nano-patch &amp; microneedle approaches could be potential delivery systems. • Targeting E6 &amp; E7 could be an effective treatment strategy for HPV-positive HNSCC.</description><subject>Carcinoma, Squamous Cell - therapy</subject><subject>CRISPR/Cas</subject><subject>Gene Editing</subject><subject>Gene Silencing</subject><subject>Head and Neck Neoplasms - therapy</subject><subject>Head and neck squamous cell carcinoma</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Human papillomavirus</subject><subject>Humans</subject><subject>Nanoparticles and lipoplex</subject><subject>Otolaryngology</subject><subject>RNA Interference</subject><subject>Short interfering RNA</subject><subject>Squamous Cell Carcinoma of Head and Neck</subject><issn>1368-8375</issn><issn>1879-0593</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqNkU1v1DAQhiNERT_gLyCLE5cEfyW2OYDQQgGpUg-Fs-U4k11vvfZie5H239dhC0KcOHmsed95Nc80zSuCO4LJ8GbbxWR8DDb6uD52FBPRYdrV1pPmgkihWtwr9rTWbJCtZKI_by5z3mKMe9LjZ805lZxJqtRFY1YmoDUEQDC54sIamTCh7DwEu_wK2E1YchxktPfmiAxK0QNyAZUNoJLAlB2EguKMNmCmX_4A9h5ZEyyk98-bs9n4DC8e36vm-_Wnb6sv7c3t56-rDzet5awv7UwEnntpubAElBio4HwkXNFJEKNGOnPBR0GlGsWoBpiY4b0a-QR1KyZGwq6a16e5-xR_HCAXvXPZgvcmQDxkTaQiUiouhyp9e5LaFHNOMOt9cjuTjppgvSDWW_03Yr0g1pjq2qrml485h3EH0x_rb6ZV8PEkgLrtTwdJZ-sqzgo4gS16iu7_ct79M8Z6F5w1_h6OkLfxkELlqYnO1aDvlmMvtyaCYcypZA90SqiA</recordid><startdate>20170501</startdate><enddate>20170501</enddate><creator>Shaikh, Mushfiq H</creator><creator>Clarke, Daniel T.W</creator><creator>Johnson, Newell W</creator><creator>McMillan, Nigel A.J</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170501</creationdate><title>Can gene editing and silencing technologies play a role in the treatment of head and neck cancer?</title><author>Shaikh, Mushfiq H ; Clarke, Daniel T.W ; Johnson, Newell W ; McMillan, Nigel A.J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-f170f58c47c1e9762744b1492d71a9b2f474b7289b7b96ed3a459b4de00037b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Carcinoma, Squamous Cell - therapy</topic><topic>CRISPR/Cas</topic><topic>Gene Editing</topic><topic>Gene Silencing</topic><topic>Head and Neck Neoplasms - therapy</topic><topic>Head and neck squamous cell carcinoma</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Human papillomavirus</topic><topic>Humans</topic><topic>Nanoparticles and lipoplex</topic><topic>Otolaryngology</topic><topic>RNA Interference</topic><topic>Short interfering RNA</topic><topic>Squamous Cell Carcinoma of Head and Neck</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shaikh, Mushfiq H</creatorcontrib><creatorcontrib>Clarke, Daniel T.W</creatorcontrib><creatorcontrib>Johnson, Newell W</creatorcontrib><creatorcontrib>McMillan, Nigel A.J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Oral oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shaikh, Mushfiq H</au><au>Clarke, Daniel T.W</au><au>Johnson, Newell W</au><au>McMillan, Nigel A.J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Can gene editing and silencing technologies play a role in the treatment of head and neck cancer?</atitle><jtitle>Oral oncology</jtitle><addtitle>Oral Oncol</addtitle><date>2017-05-01</date><risdate>2017</risdate><volume>68</volume><spage>9</spage><epage>19</epage><pages>9-19</pages><issn>1368-8375</issn><eissn>1879-0593</eissn><abstract>Highlights • Gene silencing and editing technology is now routine in the laboratory. • Advanced bioinformatics of head and neck cancer is required. • Clinically useful delivery systems and target selection are critical barriers. • The PLAS, nano-patch &amp; microneedle approaches could be potential delivery systems. • Targeting E6 &amp; E7 could be an effective treatment strategy for HPV-positive HNSCC.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>28438299</pmid><doi>10.1016/j.oraloncology.2017.02.016</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1368-8375
ispartof Oral oncology, 2017-05, Vol.68, p.9-19
issn 1368-8375
1879-0593
language eng
recordid cdi_proquest_miscellaneous_1891889486
source Elsevier
subjects Carcinoma, Squamous Cell - therapy
CRISPR/Cas
Gene Editing
Gene Silencing
Head and Neck Neoplasms - therapy
Head and neck squamous cell carcinoma
Hematology, Oncology and Palliative Medicine
Human papillomavirus
Humans
Nanoparticles and lipoplex
Otolaryngology
RNA Interference
Short interfering RNA
Squamous Cell Carcinoma of Head and Neck
title Can gene editing and silencing technologies play a role in the treatment of head and neck cancer?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T11%3A47%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Can%20gene%20editing%20and%20silencing%20technologies%20play%20a%20role%20in%20the%20treatment%20of%20head%20and%20neck%20cancer?&rft.jtitle=Oral%20oncology&rft.au=Shaikh,%20Mushfiq%20H&rft.date=2017-05-01&rft.volume=68&rft.spage=9&rft.epage=19&rft.pages=9-19&rft.issn=1368-8375&rft.eissn=1879-0593&rft_id=info:doi/10.1016/j.oraloncology.2017.02.016&rft_dat=%3Cproquest_cross%3E1891889486%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c435t-f170f58c47c1e9762744b1492d71a9b2f474b7289b7b96ed3a459b4de00037b13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1891889486&rft_id=info:pmid/28438299&rfr_iscdi=true